A number of opening-up measures have been implemented in Beijing to cover a full range of matters in the fields of health and social work. These measures will make it easier and simpler to invest and do business in Beijing.
However, there are some investment requirements and restrictions that you should be aware of in advance.
I. Foreign-funded professional health insurance institutions (maximum 50% of the shares held by foreign investors) are allowed to be established.
II. Conditions will be gradually relaxed for medical services jointly invested or provided by Chinese and foreign investors, and approval power will be delegated properly to facilitate the application process for investors.
III. New drug projects developed abroad and of great significance may, after approval from the China Food and Drug Administration, be allowed to conduct clinical trials in Beijing.
IV. In accordance with the relevant provisions of drug imports, importation of innovator drug comparator products and clinical trial drugs under development will be allowed. International multicenter clinical trials will allow the use of clinical study drugs produced by overseas R&D outsourcing companies and cGMP manufacturers in compliance with the Good Manufacturing Practice (GMP).
V. Pilot medical device registrant system will be implemented, allowing Beijing medical device registrants to entrust the production of medical devices to medical device manufacturers in Beijing, Tianjin, and Hebei.
VI. Restrictions will be eased for foreign investors to run non-profit elderly care institutions as private non-corporate entities in the form of donations.
I. Medical institutions shall be restricted to equity joint ventures.